These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 23560496)

  • 1. Inverse expression of hyaluronidase 2 and hyaluronan synthases 1-3 is associated with reduced hyaluronan content in malignant cutaneous melanoma.
    Siiskonen H; Poukka M; Tyynelä-Korhonen K; Sironen R; Pasonen-Seppänen S
    BMC Cancer; 2013 Apr; 13():181. PubMed ID: 23560496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of hyaluronan synthase 1 and 2 associates with poor prognosis in cutaneous melanoma.
    Poukka M; Bykachev A; Siiskonen H; Tyynelä-Korhonen K; Auvinen P; Pasonen-Seppänen S; Sironen R
    BMC Cancer; 2016 May; 16():313. PubMed ID: 27184066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in serous ovarian carcinomas: inverse correlation between HYAL1 and hyaluronan content.
    Nykopp TK; Rilla K; Sironen R; Tammi MI; Tammi RH; Hämäläinen K; Heikkinen AM; Komulainen M; Kosma VM; Anttila M
    BMC Cancer; 2009 May; 9():143. PubMed ID: 19435493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel role of low molecular weight hyaluronan in breast cancer metastasis.
    Wu M; Cao M; He Y; Liu Y; Yang C; Du Y; Wang W; Gao F
    FASEB J; 2015 Apr; 29(4):1290-8. PubMed ID: 25550464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma.
    Nykopp TK; Rilla K; Tammi MI; Tammi RH; Sironen R; Hämäläinen K; Kosma VM; Heinonen S; Anttila M
    BMC Cancer; 2010 Sep; 10():512. PubMed ID: 20875124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of hyaluronan synthase-2 reduces the tumorigenic potential of glioma cells lacking hyaluronidase activity.
    Enegd B; King JA; Stylli S; Paradiso L; Kaye AH; Novak U
    Neurosurgery; 2002 Jun; 50(6):1311-8. PubMed ID: 12015850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS; Shakhtour B; Shyr Y
    J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions.
    Miracco C; Cevenini G; Franchi A; Luzi P; Cosci E; Mourmouras V; Monciatti I; Mannucci S; Biagioli M; Toscano M; Moretti D; Lio R; Massi D
    Hum Pathol; 2010 Apr; 41(4):503-12. PubMed ID: 20004946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UDP-sugar substrates of HAS3 regulate its O-GlcNAcylation, intracellular traffic, extracellular shedding and correlate with melanoma progression.
    Deen AJ; Arasu UT; Pasonen-Seppänen S; Hassinen A; Takabe P; Wojciechowski S; Kärnä R; Rilla K; Kellokumpu S; Tammi R; Tammi M; Oikari S
    Cell Mol Life Sci; 2016 Aug; 73(16):3183-204. PubMed ID: 26883802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-suppressive functions of 4-MU on breast cancer cells of different ER status: Regulation of hyaluronan/HAS2/CD44 and specific matrix effectors.
    Karalis TT; Heldin P; Vynios DH; Neill T; Buraschi S; Iozzo RV; Karamanos NK; Skandalis SS
    Matrix Biol; 2019 May; 78-79():118-138. PubMed ID: 29673760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moesin and CD44 expression in cutaneous melanocytic tumours.
    Ichikawa T; Masumoto J; Kaneko M; Saida T; Sagara J; Taniguchi S
    Br J Dermatol; 1998 May; 138(5):763-8. PubMed ID: 9666819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential hyaluronan homeostasis and expression of proteoglycans in juvenile and adult human skin.
    Tzellos TG; Sinopidis X; Kyrgidis A; Vahtsevanos K; Triaridis S; Printza A; Klagas I; Karakiulakis G; Papakonstantinou E
    J Dermatol Sci; 2011 Jan; 61(1):69-72. PubMed ID: 21087840
    [No Abstract]   [Full Text] [Related]  

  • 13. CD44 and variants in melanocytic skin neoplasms.
    Schaider H; Soyer HP; Heider KH; Hofmann-Wellenhof R; Zatloukal K; Smolle J; Kerl H
    J Cutan Pathol; 1998 Apr; 25(4):199-203. PubMed ID: 9609138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. V3 versican isoform alters the behavior of human melanoma cells by interfering with CD44/ErbB-dependent signaling.
    Hernández D; Miquel-Serra L; Docampo MJ; Marco-Ramell A; Cabrera J; Fabra A; Bassols A
    J Biol Chem; 2011 Jan; 286(2):1475-85. PubMed ID: 21078678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PP2B and ERK1/2 regulate hyaluronan synthesis of HT168 and WM35 human melanoma cell lines.
    Katona É; Juhász T; Somogyi CS; Hajdú T; Szász C; Rácz K; Kókai E; Gergely P; Zákány R
    Int J Oncol; 2016 Mar; 48(3):983-97. PubMed ID: 26717964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomimetic tissue models reveal the role of hyaluronan in melanoma proliferation and invasion.
    Sapudom J; Nguyen KT; Martin S; Wippold T; Möller S; Schnabelrauch M; Anderegg U; Pompe T
    Biomater Sci; 2020 Mar; 8(5):1405-1417. PubMed ID: 31939453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nodular basal cell carcinoma is associated with increased hyaluronan homeostasis.
    Tzellos TG; Kyrgidis A; Vahtsevanos K; Triaridis S; Printza A; Klagas I; Zvintzou E; Kritis A; Karakiulakis G; Papakonstantinou E
    J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):679-87. PubMed ID: 20849445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 and melanocytic tumors: a possible role for standard CD44 in the epidermotropic spread of melanoma.
    Fernández-Figueras MT; Ariza A; Calatrava A; Puig L; Fernández-Vasalo A; Ferrándiz C
    J Cutan Pathol; 1996 Apr; 23(2):133-9. PubMed ID: 8721447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma.
    Fang D; Hallman J; Sangha N; Kute TE; Hammarback JA; White WL; Setaluri V
    Am J Pathol; 2001 Jun; 158(6):2107-15. PubMed ID: 11395388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of hyaluronan synthase and hyaluronidase mRNA may affect hyaluronic acid distribution in keloid disease compared with normal skin.
    Sidgwick GP; Iqbal SA; Bayat A
    Exp Dermatol; 2013 May; 22(5):377-9. PubMed ID: 23614752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.